In the second quarter of 2013, the ongoing company retired its outstanding 8.0 percent senior secured convertible notes due August 2014 in the principal amount of $39 million resulting in a noncash loss of $3.3 million. In 2012, income of $13.4 million was generated primarily because of one-time payments received via an extended agreement with GlaxoSmithKline and through a license of non-core technologies. Recent and Fourth Quarter 2013 Highlights: Determined three CPM lead applicants which will advance into IND-enabling advancement.The full total results of the U.S. Offer will be announced on Sept. 26, 2014, at the proper time the outcomes of the Chilean tender offer for CFR ordinary shares are announced. Orrin Hatch, R-Utah, and Charles Grassley, R-Iowa, allege the White Home's delayed decisions kept wellness officials from meeting advancement deadlines for the online exchanges, Reuters reports. In the meantime, a GAO established tells a Senate panel that the federal government has a flawed strategy on tech Crash Two Republican senators on Thursday issued a report accusing the Obama administration of pushing ahead with last October's botched rollout of site despite internal problems that the technology would not work.